KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 104 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,000 | +146.0% | 7,053 | +100.2% | 0.00% | – |
| Q2 2023 | $50,000 | +85.2% | 3,523 | +44.2% | 0.00% | – |
| Q1 2023 | $27,000 | -62.0% | 2,443 | -48.1% | 0.00% | – |
| Q4 2022 | $71,000 | +787.5% | 4,706 | +642.3% | 0.00% | – |
| Q3 2022 | $8,000 | +100.0% | 634 | +48.8% | 0.00% | – |
| Q2 2022 | $4,000 | -80.0% | 426 | -79.1% | 0.00% | – |
| Q1 2022 | $20,000 | -74.4% | 2,041 | -69.2% | 0.00% | – |
| Q4 2021 | $78,000 | +129.4% | 6,623 | +124.5% | 0.00% | – |
| Q3 2021 | $34,000 | +9.7% | 2,950 | +31.3% | 0.00% | – |
| Q2 2021 | $31,000 | -51.6% | 2,246 | -35.8% | 0.00% | – |
| Q1 2021 | $64,000 | +82.9% | 3,501 | +72.4% | 0.00% | – |
| Q4 2020 | $35,000 | +94.4% | 2,031 | +74.0% | 0.00% | – |
| Q3 2020 | $18,000 | +500.0% | 1,167 | +721.8% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 142 | +195.8% | 0.00% | – |
| Q1 2020 | $1,000 | -92.3% | 48 | -96.0% | 0.00% | – |
| Q4 2019 | $13,000 | +225.0% | 1,196 | +724.8% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 145 | -37.0% | 0.00% | – |
| Q3 2018 | $6,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |